NeuroMed Devices Awards Contract to Syprosoft Engineering
IRVINE, Calif.--(BUSINESS WIRE)-- NeuroMed Devices, Inc. has contracted Syprosoft Engineering for assistance with the development of the OraCalm and ViraCalm products. Both are neuromodulation devices and are designed for the treatment of oral and genital herpes.
“We picked Syprosoft Engineering due to their experience with computerized medical devices and the regulatory requirements for software,” said Shep Bentley, Chief Executive Officer of NeuroMed Devices, Inc. “They have done an excellent job on an accelerated schedule with the OraCalm project and are now embarked on the ViraCalm project,” concluded Mr. Bentley.
“We are pleased to be chosen again by NeuroMed Devices, Inc. for assistance with their product development efforts,” said Dipu Ghosh, President & Founder of Syprosoft Engineering. “We look forward to continuing to provide real value to NeuroMed Devices, Inc. as we become an extension of their own engineering department.”
About NeuroMed Devices NeuroMed Devices, Inc. is the world's foremost innovator of non-invasive therapeutic neuromodulation. With its internationally patented and clinically proven approaches to neuromodulation, the company will be introducing a variety of safe and effective devices for the treatment of a wide array of neurological indications.
About Syprosoft Engineering Founded in 2002, Syprosoft Inc. is a privately held company located in Irvine, California. Syprosoft Engineering, a division of Syprosoft Inc., provides a full range of R&D services, including systems, software, electrical and mechanical engineering. As an extension of a client’s engineering department, Syprosoft Engineeringprovides the critical skills and expertise at the right time to help its clients meet their product development goals. For more information please visit www.syprosoft.com.
Disclaimer This press release contains forward-looking statements. These are based on current expectations and beliefs and are subject to numerous risks, uncertainties and change. The parties disclaim any obligation to update any forward-looking statement as a result of developments occurring after this press release.